These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3346067)

  • 1. Implication of leumorphin in inhibitory control of vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Mukoyama M; Arai H
    Hypertension; 1988 Feb; 11(2 Pt 2):I80-3. PubMed ID: 3346067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory action of leumorphin on vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Mukoyama M; Arai H
    Endocrinology; 1988 Mar; 122(3):985-90. PubMed ID: 3342763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leumorphin is a potent inhibitor of vasopressin secretion.
    Yamada T; Nakao K; Itoh H; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Katsuura G; Eigyo M
    NIDA Res Monogr; 1986; 75():335-8. PubMed ID: 3123947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent depressor action of leumorphin, a kappa-opioid agonist, in conscious rats.
    Itoh H; Nakao K; Yamada T; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Mukoyama M; Arai H
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):256-61. PubMed ID: 2839205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent action of leumorphin on consummatory behaviors in rats: comparison with other opioid peptides.
    Imura H; Nakao K; Yanaihara N; Katsuura G; Nakamura M
    Neuroendocrinology; 1986; 44(2):142-8. PubMed ID: 3796789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid modulation of vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Shirakami G; Sugawara A; Saito Y; Mukoyama M; Arai H; Hosoda K; Morii N
    Clin Exp Hypertens A; 1988; 10 Suppl 1():361-7. PubMed ID: 3243002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of naloxone on vasopressin secretion in conscious rats: evidence for inhibitory role of endogenous opioid peptides in vasopressin secretion.
    Yamada T; Nakao K; Itoh H; Shirakami G; Sugawara A; Saito Y; Mukoyama M; Arai H; Hosoda K; Shiono S
    Endocrinology; 1989 Aug; 125(2):785-90. PubMed ID: 2546748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centrally administered leumorphin possesses potent depressor activity in conscious rats.
    Itoh H; Nakao K; Yamada T; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Katsuura G; Shiomi T
    NIDA Res Monogr; 1986; 75():512-5. PubMed ID: 3123970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa-opioid modulation of vasopressin secretion in conscious rats.
    Wells T; Forsling ML
    J Endocrinol; 1991 Jun; 129(3):411-6. PubMed ID: 1648591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leumorphin is a potent, kappa opioid receptor agonist.
    Suda M; Nakao K; Yoshimasa T; Sakamoto M; Morii N; Ikeda Y; Yanaihara C; Yanaihara N; Numa S; Imura H
    Neurosci Lett; 1984 Sep; 50(1-3):49-52. PubMed ID: 6149506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel opioid peptide, leumorphin, acts as an agonist at the kappa opiate receptor.
    Suda M; Nakao K; Yoshimasa T; Ikeda Y; Sakamoto M; Yanaihara N; Numa S; Imura H
    Life Sci; 1983 Jun; 32(24):2769-75. PubMed ID: 6134225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centrally administered tuberoinfundibular peptide of 39 residues inhibits arginine vasopressin release in conscious rats.
    Sugimura Y; Murase T; Ishizaki S; Tachikawa K; Arima H; Miura Y; Usdin TB; Oiso Y
    Endocrinology; 2003 Jul; 144(7):2791-6. PubMed ID: 12810532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation by leumorphin of prolactin secretion from the pituitary in rats.
    Tojo K; Kato Y; Ohta H; Matsushita N; Shimatsu A; Kabayama Y; Inoue T; Yanaihara N; Imura H
    Endocrinology; 1985 Sep; 117(3):1169-74. PubMed ID: 2862017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centrally administered galanin inhibits osmotically stimulated arginine vasopressin release in conscious rats.
    Kondo K; Murase T; Otake K; Ito M; Oiso Y
    Neurosci Lett; 1991 Jul; 128(2):245-8. PubMed ID: 1719452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebroventricular injection of brain natriuretic peptide inhibits vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Shirakami G; Kangawa K; Minamino N; Matsuo H; Imura H
    Neurosci Lett; 1988 Dec; 95(1-3):223-8. PubMed ID: 3226610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic responses of conscious rats following intrathecal injections of prodynorphin-derived opioids: independence of action of intrathecal arginine vasopressin.
    Thornhill JA; Pittman QJ
    Can J Physiol Pharmacol; 1990 Feb; 68(2):174-82. PubMed ID: 1968777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leumorphin has an anti-apoptotic effect by activating epidermal growth factor receptor kinase in rat pheochromocytoma PC12 cells.
    Lee BD; Kim S; Hur EM; Park YS; Kim YH; Lee TG; Kim KT; Suh PG; Ryu SH
    J Neurochem; 2005 Oct; 95(1):56-67. PubMed ID: 16181412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the action of putative endogenous kappa-agonists, leumorphin and rimorphin in vitro.
    Suda M; Nakao K; Yoshimasa T; Ikeda Y; Sakamoto M; Yanaihara C; Yanaihara N; Numa S; Imura H
    Life Sci; 1983; 33 Suppl 1():275-8. PubMed ID: 6319876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of endogenous opioid peptides in the inhibition of arginine vasopressin release by gamma-aminobutyric acid in conscious rats.
    Otake K; Kondo K; Oiso Y
    Neuroendocrinology; 1991 Aug; 54(2):170-4. PubMed ID: 1766553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the immunoreactivities of an opioid peptide leumorphin in the hypothalamus and anterior pituitary during the estrous cycle of the rat and their relation to sexual behavior.
    Suda M; Nakao K; Sakamoto M; Morii N; Sugawara A; Imura H
    Brain Res; 1986 May; 374(2):236-43. PubMed ID: 2872940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.